AIM Vaccine Submits Pre-Applications for Clinical Trials for MRNA RSV, Shingles Vaccines
AIM Vaccine Submits Pre-Applications for Clinical Trials for MRNA RSV, Shingles Vaccines
艾美疫苗(臨時代碼)提交預備申請，進行MRNA RSV和帶狀皰疹疫苗的臨牀試驗。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊